TP53 and neoplasm: To investigate whether PCYT1B expression can also be influenced by tumor-associated mutant p53, we knocked down p53 expression in MDA-MB-231 cells (carrying the p53R280K mutation) and DU145 cells (heterozygous p53P223L/V274F) via siRNA interference.